.png){kind=icon}
.png){kind=icon}
Return
FDA new drug approvals in Q2 2026
.png){kind=icon}
PRE
AI
P
DOI：10.1038/d41573-026-00120-7.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
Journal
IF:
101.8
Papers:
5.1K
Citations:
5.3W
Organization
No organization information available
Cited Papers
Paul Verdin
Original request for helpShareSave